SA
Sekh Alamgir
About Sekh Alamgir
Data last updated:
Sekh Alamgir is a Director at Sanbiocem Pharma Private Limited (since 2022), Additional Director at Metrolife Foundation (since 2025) and Designated Partner at Vedanto Contracts Llp (since 2025), and holds 2 more current directorships. The companies operate in Electrnoics, Non-Profit Organizations and Healthcare. The largest current company by reported revenue is Sanbiocem Pharma Private Limited at ₹99,123 (FY 2021). Earlier, Sekh Alamgir was a Director at Roseview Realty Private Limited (2025) and Director at Vedanto Pharma Limited (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Jan 2022 | 2020 | ₹99,123 (FY 2021) | Active | |
| Additional Director | 11 Apr 2025 | 2021 | Active | ||
| Designated Partner | 21 Mar 2025 | 2025 | Active | ||
| Designated Partner | 02 Jan 2023 | 2023 | Active | ||
| Designated Partner | 07 Oct 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Apr 2025 | 2025 | Active | ||
| Director | 14 Mar 2024 | 2024 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sekh Alamgir
| Name | DIN | Company | Designation |
|---|---|---|---|
| Santanu Kumar Mandal | 06561216 | Sanbiocem Pharma Private Limited , Metrolife Foundation and 3 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sekh Alamgir
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sekh Alamgir
Sekh Alamgir currently holds 5 directorships: Sanbiocem Pharma Private Limited (Director, since 12 Jan 2022, revenue βΉ99,123 (FY 2021)); Metrolife Foundation (Additional Director, since 11 Apr 2025); Vedanto Contracts Llp (Designated Partner, since 21 Mar 2025); Vedanto Biomedical Llp (Designated Partner, since 02 Jan 2023); Logicbase Consulting Llp (Designated Partner, since 07 Oct 2022).
Sekh Alamgir was first appointed on 12 Jan 2022 as Director at Sanbiocem Pharma Private Limited. The most recent appointment on record is 24 Apr 2025 at Roseview Realty Private Limited.
Sekh Alamgir held 2 earlier board appointments: Roseview Realty Private Limited (Director, 24 Apr 2025 to 26 Apr 2025); Vedanto Pharma Limited (Director, 14 Mar 2024 to 30 Apr 2025).
The current boards of Sekh Alamgir's companies include Santanu Kumar Mandal (Sanbiocem Pharma Private Limited).